Cytokinetics (CYTK) Misses Q1 EPS by 19c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $80.80 --0%
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -46.4%
Financial Fact:
Net loss: 31.89M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q1 EPS of ($1.33), $0.19 worse than the analyst estimate of ($1.14). Revenue for the quarter came in at $840 thousand versus the consensus estimate of $1.05 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Bernstein SocGen Group Resumes Thermo Fisher Scientific (TMO) at Market Perform
- Piper Sandler Assumes Provident Financial Holdings (PROV) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
